Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Dense-star-polymers-and-dendrimers

 Intermediates for providing functional groups on the 5' end of oligonucleotides
We claim: 1. A partially protected alcohol of the formula: ##STR10## wherein Y.sup.1 is selected ...


 Antiviral polynucleotide conjugates
OF THE INVENTION The present invention provides polynucleotide conjugates characterized by the ...


 Azlactone activated polyalkylene oxides conjugated to biologically active nucleophiles
OF THE PREFERRED EMBODIMENT The azlactone activated polyalkylene oxides of the present invention ...


 Biologically compatible linear block copolymers of polyalkylene oxide and peptide units
INCLUSIVE OF PREFERRED EMBODIMENTS We have discovered that linear block copolymers comprising ...


 Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces
The present invention provides for compounds having the formula: ##STR1## wherein R.sub.1 is ...


 Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
OF THE INVENTION The following examples are given to illustrate the invention, but should not be ...


 Polyoxypropylene/polyoxyethylene copolmers with improved biological activity
Although the prior art preparations of polyoxypropylene/polyoxyethylene block copolymers may have ...


 Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides
We claim: 1. A compound of the formula ##STR10## where (a) X.sup.1 is chlorine and X.sup.2 is ...


 Nucleic acid probes immobilized on polystyrene surfaces
We claim: 1. An article of manufacture for use in a solution phase nucleic acid sandwich ...


 Star polymers having multiple polyisobutylene arms emanating from a calixarene core, initiators therefor, and method for the synthesis thereof
What is claimed is: 1. A composition of matter comprising: a core component selected from the group ...


 Dense star polymers and dendrimers

Details
Inventors: Tomalia, Donald A.; Dewald, James R.;
Assignee: The Dow Chemical Company (Midland, MI)
Primary Examiner:
Assistant Examiner:
Attorney, Agent or Firm:

Dense star polymers having terminal group densities greater than conventional star polymers exhibit greater and more uniform reactivity than their corresponding conventional star polymers. For example, a third generation, amine-terminated polyamidoamine dense star polymer prepared from ammonia, methyl acrylate and ethylenediamine has 1.24.times.10.sup.-4 amine moieties per unit volume (cubic Angstrom units) in contrast to the 1.58.times.10.sup.-6 amine moieties per unit volume contained by a conventional star polymer. Such dense star polymers are useful as demulsifiers for oil/water emulsions, wet strength agents in the manufacture of paper, and agents for modifying viscosity in aqueous formulations such as paints.

DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS In the dense star polymers of the present invention, the core is covalently bonded to at least one core branch, preferably at least two, most preferably at least three, core branches with each core branch having a calculated length of at least 3 Angstrom units (A), preferably at least 4 A, most preferably at least 6 A.
These polymers preferably have an average of at least 2, more preferably at least 3 and most preferably at least 4 terminal groups per polymer molecule.
Preferably, the core branches have a dendritic character, most preferably an ordered dendritic character as defined hereinafter.
The dense star polymers of this invention preferably have two-dimensional molecular diameters in the range from about 12 to about 2000 Angstrom units (A), more preferably from about 25 to about 500 A and most preferably from about 250 A.
For the purpose of this invention, a two-dimensional molecular diameter is determined by the following electron microscopic method.
First, the terminal groups of dendrimers are connected to anionic moieties (e.
g.
, by hydrolysis of the terminal ester moieties of polyamidoamine dendrimer in half generation state).
The anionic dendrimer molecules are then neutralized with stoichiometric amounts of alkali metal hydroxide.
A dilute aqueous solution (e.
g.
, about 0.
5 weight percent of the neutralized dendrimer in water) of the dendrimer is placed on a beryllium grid (.
about.
1.
5 millimeter diameter puddle) and allowed to evaporate.
The dendrimer often exhibits dendritic-like crystalline growth during the evaporation process.
The diameter of the dry dendrimer molecules in two-dimensional state are then measured by electron microscopy and found to correspond closely, e.
g.
, within 15 percent, to the diameters predicted by scaled Corey-Pauling molecular models.
Such measurements are readily made using a JEM-1200 EX Electron Microscope sold by JEOL Corporation using CTEM techniques on a beryllium grid coated with 50 A carbon.
The dense star polymers of this invention preferably have three-dimensional molecular diameters in the range from about 6 to about 1000, more preferably from about 10 to about 250, most preferably from about 25 to about 125 Angstrom units



Related patents
  Glycerin derivatives and inhibition of blood PAF
OF THE INVENTION The glycerine derivatives of the invention are compounds of the formula ##STR3## wherein one of the residues R.sup.1, R.sup.2 and R.sup.3 is group U of ...
  Oligonucleotide derivatives and production thereof
Gist In view of the state of the art as described above, the present inventors have developed an immobilized oligonucleotide which is useful in purification of nucleic ...
  Process for synthesizing macrocyclic chelates
The invention is a process for synthesizing a 12 membered ring tetraaza macromolecule. The process involves condensing an amide of ethylene diamine having a general ...
  Immunoconjugates joined by thioether bonds having reduced toxicity and improved selectivity
I claim: 1. A method for producing a 1:1 protein:anitbody tioether-linked immunoconjugate as a predominant species, comprising the steps of: combining a protein selected ...
  Compositions for photodynamic therapy
I claim: 1. A pharmaceutical composition useful for photodynamic therapy which composition contains, as active ingredient, a conjugate of a porphyrin-type ...
  Amplifier molecules for enhancement of diagnosis and therapy
As used herein, an "amplifier" or "amplifier molecule" is a chemical compound having a multiplicity of terminal amine moieties, each serving as a locus to which one or ...
  Peptide-containing polyethylene glycol derivatives and application thereof
OF THE PREFERRED EMBODIMENTS The present invention will hereinafter be explained in more detail. The peptide-containing polyethylene glycol derivatives of the present ...
  Modified HIL-6
OF THE INVENTION Described below is the chemical modification with PEG of at least one amino group of polypeptides possessing IL-6 activities. This modification results ...
  Construction of geometrical objects from polynucleotides
By means of the present invention, DNA, RNA and similar polymers may be produced by synthesizing a double stranded segment, preferably with a loop at one end, cleaving ...
  Starburst conjugates
In its broadest aspect, the present invention is directed to polymer conjugate materials comprising dense star polymers or starburst polymers associated with desired ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved